SCHEMBL23660972

SCHEMBL23660972

Cc1nc(-c2cc(-c3ccccc3)cc(-c3ccccc3)c2)cc(-c2cc(-c3ccccc3)cc(-c3ccc(-c4cccc(-c5cc(-c6ccccc6)cc(-c6nc(C)nc(-c7cc(-c8ccccc8)cc(-c8ccccc8)c7)n6)c5)c4)cc3)c2)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.56
KMT2A Q03164 11/20 0.49
MEN1 O00255 10/20 0.49
MAPT P10636 9/20 0.49
ALDH1A1 P00352 7/20 0.49
HPGD P15428 6/20 0.49
KDM4E B2RXH2 5/20 0.46
LMNA P02545 4/20 0.46
GLA P06280 1/20 0.46
NTSR1 P30989 1/20 0.45
TDP1 Q9NUW8 1/20 0.42
TP53 P04637 2/20 0.40
POLB P06746 2/20 0.40
PKM P14618 1/20 0.40
RAB9A P51151 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
CYP2C19 P33261 1/20 0.40
GAA P10253 1/20 0.40
AGTR1 P30556 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12166274 0.88 L3MBTL1 (0.67) L3MBTL1KMT2AMEN1MAPTALDH1A1
SCHEMBL12166275 0.88 KMT2A (0.46) L3MBTL1KMT2AMEN1MAPTALDH1A1
SCHEMBL16305242 0.88 MEN1 (0.55) L3MBTL1KMT2AMEN1MAPTALDH1A1
SCHEMBL22309290 0.87 L3MBTL1 (0.61) L3MBTL1KMT2AMEN1MAPTALDH1A1
SCHEMBL25460697 0.87 KMT2A (0.50) L3MBTL1KMT2AMEN1MAPTALDH1A1
SCHEMBL25460795 0.87 KMT2A (0.50) L3MBTL1KMT2AMEN1MAPTALDH1A1
SCHEMBL25460959 0.86 L3MBTL1 (0.51) L3MBTL1KMT2AMEN1MAPTALDH1A1
SCHEMBL14425548 0.86 MEN1 (0.55) L3MBTL1KMT2AMEN1MAPTALDH1A1
SCHEMBL12166279 0.86 L3MBTL1 (0.69) L3MBTL1KMT2AMEN1MAPTALDH1A1
SCHEMBL18562524 0.86 KMT2A (0.55) L3MBTL1KMT2AMEN1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760734-B2 Materials for organic electroluminescent devices MERCK PATENT GMBH (DE) 2023-09-19 US disclosed
US-20210221775-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210221775-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SLCO4C1, SLCO2B1, SLCO2A1 L3MBTL1 2132/4885KMT2A 2454/4885MEN1 665/4885
US-11760734-B2 Materials for organic electroluminescent devices SLCO4C1, SLCO2B1, SLCO2A1 L3MBTL1 2132/4885KMT2A 2454/4885MEN1 665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.